MATWIN is an accelerator program aiming at maximizing innovation transfer potential exclusively on oncology. Relying on the existing national ecosystem (canceropoles, SIRIC, technology transfer offices, clusters etc.) and on Unicancer preclinical and clinical network, MATWIN identifies and supports high level oncology research projects with a high development potential. The provided support aims at optimizing the projects’ industrial attractiveness and at boosting its development.
Non-French European applicants* (academic or start-up) can apply if they can prove that they have collaboration with French partners (academic team or company).
To apply to MATWIN’s programme, project leaders have 2 possible processes. The principle: the most upstream the application is submitted the most developed MATWIN’s support is. Check both support processes details here.
- Classic process (6 months): application possible until 10 November 2022 at the latest; file to be completed (downloadable below)
- Fast-Track process (3 months): application possible until February 28, 2023; submit your presentation (5 slides max) with audio support.
You can access MATWIN’s expertise throughout the year (see “Our service offers” section) but to benefit from the support program for a possible hearing by the MATWIN Board in May 2023, the applications submission is expected by the deadlines indicated above.
*Candidates from Switzerland, UK and Norway can apply